RAPPORT THERAPEUTICS INC. - COMMON STOCK

Rapport Therapeutics to Participate in Upcoming Investor Conferences

22 أبريل 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting

21 مارس 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

11 مارس 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

03 مارس 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Rapport Therapeutics to Participate in Upcoming Investor Conferences

24 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 يناير 2025 09:12:59 بحسب Nasdaq GlobeNewswire

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

06 ديسمبر 2024 12:01:00 بحسب Nasdaq GlobeNewswire

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

14 نوفمبر 2024 07:00:02 بحسب Nasdaq GlobeNewswire

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

07 نوفمبر 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

04 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

05 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire